ETC
AGN

Exchange Traded Concepts’s Allergan plc AGN Stock Holding History

Exchange Traded Concepts’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,319
Closed -$1.83M – 888
2020
Q1 		$1.83M Buy
10,319
+8,132
+372% +$1.53M 0.99% 16
2019
Q4 		$418K Buy
+2,187
New +$395K 0.09% 138

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Exchange Traded Concepts's AGN Position: Q2 2020 in Review

Exchange Traded Concepts sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 10,319 shares — an estimated $1.83M sold.

Exchange Traded Concepts first reported a position in AGN in Q4 2019 and held it in 2 quarters. The position peaked at $1.83M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Exchange Traded Concepts reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Exchange Traded Concepts sold 10,319 Allergan plc shares in Q2 2020, an estimated $1.83M.
  • Exchange Traded Concepts first reported a position in Allergan plc in Q4 2019 and held it in 2 quarters.
  • Exchange Traded Concepts's Allergan plc position peaked at $1.83M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Exchange Traded Concepts's 13F filing for Q2 2020, filed 15 Jul 2020.